Skip to search formSkip to main contentSkip to account menu

rimiterol

Known as: 1,2-Benzenediol, 4-(hydroxy-2-piperidinylmethyl)-, (R*,S*)- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
Highly Cited
1984
Highly Cited
1984
Selective adrenoceptor agonists and antagonists have been used to analyse the effects of stimulation of individual types of… 
Highly Cited
1981
Highly Cited
1981
  • C. George
  • Clinical Pharmacokinetics
  • 1981
  • Corpus ID: 45987514
Circumstantial evidence for first-pass metabolism across the gastrointestinal mucosa includes reduced bioavailability after oral… 
Highly Cited
1980
Highly Cited
1980
The metabolic and cardiovascular side-effects of intravenous infusions of therapeutic doses of beta 2-adrenoceptor agonists… 
1975
1975
The bronchodilating efficacies and beta2-adrenoceptor selectivities of rimiterol (0.2, 0.1, and 0.05 mug kg-minus1 min-minus1… 
1975
1975
1 The bronchodilating efficacy and the degree of beta2-adrenoceptor selectivity of rimiterol, salbutamol and isoprenaline were… 
1974
1974
The bronchodilator and cardiac effects produced by aerosols of 0·5% salbutamol and 0·5% and 1% rimiterol administered for three… 
1974
1974
  • I. Rodger
  • Clinical and Experimental Pharmacology and…
  • 1974
  • Corpus ID: 2834793
SUMMARY 1. A method for assessing the bronchodilator potency of sympathomimetics in anaesthetized cats is described. 
Highly Cited
1972
Highly Cited
1972
1 The actions of rimiterol [erythro(3,4‐dihydroxyphenyl, 2‐piperidyl methanol hydrobromide)], a new sympathomimetic…